Spermosens are active in medical technology. The company specializes in the development of medical devices. The product portfolio is broad and includes products for male infertility and individually tailored fertility treatments. Research and development is conducted via its own technological platform that analyzes sperm quality, which is further used for medical data and potential fertilization. The largest operations are in the Nordic market.
CEO
Chairman Of The Board
Board
| Name | Capital % | Votes % | Date |
|---|---|---|---|
| Kushagr Punyani | 16,61 | 16,61 | 2021-05-05 |
| Sudha Srivastava | 7,26 | 7,26 | 2021-05-05 |
| Mohamad Takwa | 4,07 | 4,07 | 2021-05-05 |
| Johan Källstrand | 3,63 | 3,63 | 2021-05-05 |
| Bertil Lindkvist | 3,16 | 3,16 | 2021-05-05 |
| Emilie Hultin Takwa | 3,16 | 3,16 | 2021-05-05 |
| Polynom Investment AB | 2,95 | 2,95 | 2021-05-05 |
| Jens Erik Martin Olsson | 2,44 | 2,44 | 2021-05-05 |
| John Moll | 2,43 | 2,43 | 2021-05-05 |
| Jimmie Landerman | 2,37 | 2,37 | 2021-05-05 |
2021-08-19 Delårsrapport 2021-Q2
2021-11-11 Delårsrapport 2021-Q3
2022-02-10 Bokslutskommuniké 2021